ProShares Ultra Nasdaq Biotechnology is a n/a business based in the US. ProShares Ultra Nasdaq Biotechnology shares (BIB) are listed on the NASDAQ and all prices are listed in US Dollars.
How to buy shares in ProShares Ultra Nasdaq Biotechnology
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BIB – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

What's in this guide?
ProShares Ultra Nasdaq Biotechnology stock price (NASDAQ: BIB)
Use our graph to track the performance of BIB stocks over time.ProShares Ultra Nasdaq Biotechnology shares at a glance
Latest market close | $50.50 |
---|---|
52-week range | $38.42 - $112.00 |
50-day moving average | $47.83 |
200-day moving average | $68.34 |
Wall St. target price | N/A |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | N/A |
Buy ProShares Ultra Nasdaq Biotechnology shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy ProShares Ultra Nasdaq Biotechnology stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ProShares Ultra Nasdaq Biotechnology price performance over time
Historical closes compared with the close of $50.5 from 2022-07-01
1 week (2022-06-24) | -0.98% |
---|---|
1 month (2022-06-03) | 5.67% |
3 months (2022-04-01) | -21.83% |
6 months (2022-01-03) | -38.65% |
1 year (2021-07-02) | -49.40% |
---|---|
2 years (2020-07-02) | -32.03% |
3 years (2019-07-03) | 53.47 |
5 years (2017-07-03) | 53.78 |
ProShares Ultra Nasdaq Biotechnology financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | 0% |
Return on equity TTM | 0% |
Profit margin | 0% |
Book value | N/A |
Market capitalisation | $0 |
TTM: trailing 12 months
ProShares Ultra Nasdaq Biotechnology share dividends
We're not expecting ProShares Ultra Nasdaq Biotechnology to pay a dividend over the next 12 months.
ProShares Ultra Nasdaq Biotechnology share price volatility
Over the last 12 months, ProShares Ultra Nasdaq Biotechnology's shares have ranged in value from as little as $38.42 up to $112. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ProShares Ultra Nasdaq Biotechnology's is 1.58. This would suggest that ProShares Ultra Nasdaq Biotechnology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
ProShares Ultra Nasdaq Biotechnology overview
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified. .
Frequently asked questions
More guides on Finder
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
-
How to buy Warrantee (WRNT) stock when it goes public
Everything we know about the Warrantee IPO, plus information on how to buy in.
-
How to buy Treasure Global (TGL) stock when it goes public
Everything we know about the Treasure Global IPO, plus information on how to buy in.
-
How to buy BIOLIFE4D (SAVU) stock when it goes public
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.
Ask an Expert